Ameriflex Group Inc. Sells 3,502 Shares of CVS Health Corporation $CVS

Ameriflex Group Inc. lessened its stake in shares of CVS Health Corporation (NYSE:CVS) by 86.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 569 shares of the pharmacy operator’s stock after selling 3,502 shares during the quarter. Ameriflex Group Inc.’s holdings in CVS Health were worth $39,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in CVS. Vest Financial LLC raised its position in shares of CVS Health by 73.5% in the first quarter. Vest Financial LLC now owns 16,707 shares of the pharmacy operator’s stock valued at $1,132,000 after purchasing an additional 7,077 shares during the period. SeaCrest Wealth Management LLC grew its stake in CVS Health by 4.4% in the 1st quarter. SeaCrest Wealth Management LLC now owns 8,136 shares of the pharmacy operator’s stock valued at $551,000 after buying an additional 344 shares during the last quarter. Pines Wealth Management LLC bought a new position in CVS Health in the 1st quarter worth $340,000. Sivia Capital Partners LLC bought a new stake in CVS Health during the first quarter valued at about $241,000. Finally, Eagle Wealth Strategies LLC acquired a new stake in shares of CVS Health in the first quarter valued at about $241,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

NYSE CVS opened at $77.51 on Monday. The stock has a market cap of $98.31 billion, a P/E ratio of 21.65, a PEG ratio of 0.85 and a beta of 0.60. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $79.20. The company’s 50-day simple moving average is $70.71 and its 200 day simple moving average is $67.32.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. During the same period in the previous year, the business earned $1.83 earnings per share. The company’s quarterly revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on CVS shares. Cantor Fitzgerald reissued an “overweight” rating and set a $78.00 price objective on shares of CVS Health in a research report on Tuesday, August 26th. Morgan Stanley upped their price target on CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Wolfe Research raised their price objective on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research note on Saturday, September 27th. Finally, Cowen restated a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $78.25.

Insider Activity at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the sale, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.22% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.